Australia markets open in 2 hours 30 minutes

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
7.000.00 (0.00%)
At close: 10:32AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-36,160
-43,267
-40,489
-39,410
-32,547
-
Depreciation & amortisation
407
498
482
427
496
-
Deferred income taxes
-
-
-
4,411
3,018
2,308
Stock-based compensation
10,369
13,050
10,252
8,632
4,395
-
Change in working capital
3,597
-11,662
-8,263
38,845
18,656
-
Accounts receivable
-6,820
314
-584
27,483
-29,302
-
Other working capital
-34,940
-39,395
-45,896
5,472
-11,290
-
Other non-cash items
-5,384
706
-1,272
42
-4,669
-
Net cash provided by operating activities
-34,253
-39,350
-45,456
6,806
-10,776
-
Cash flows from investing activities
Investments in property, plant and equipment
-687
-45
-440
-1,334
-514
-
Purchases of investments
-60,105
-20,666
-16,125
0
0
-
Sales/maturities of investments
-
36,183
0
10,000
10,000
-
Other investing activities
-
-
-
-
-544
-
Net cash used for investing activities
4,324
16,430
-16,542
8,676
9,618
-
Cash flows from financing activities
Debt repayment
-113
-174
-190
-211
-402
-
Common stock issued
43,118
25,329
43,239
30,922
15,830
-
Net cash used provided by (used for) financing activities
43,005
25,155
43,049
30,711
15,428
-
Net change in cash
13,076
2,235
-18,949
46,193
14,270
-
Cash at beginning of period
71,469
54,816
73,537
27,449
13,515
-
Cash at end of period
84,545
54,031
54,816
73,537
27,449
-
Free cash flow
Operating cash flow
-34,253
-39,350
-45,456
6,806
-10,776
-
Capital expenditure
-687
-45
-440
-1,334
-514
-
Free cash flow
-34,940
-39,395
-45,896
5,472
-11,290
-